PKR is not required for interferon-γ inhibition of VSV replication in neurons

Viral Immunology

Volumn 16, Issue 1, 2003, Pages 87-96

  Chesler, David A ^a   Muñoz Jordán, Jorge Luis ^c   Donelan, Nicola ^c   García Sastre, Adolfo ^c   Reiss, Carol Shoshkes ^a,b,c  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; GAMMA INTERFERON; INITIATION FACTOR 2; PROTEIN KINASE;

ARTICLE; CELL LINE; CENTRAL NERVOUS SYSTEM INFECTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NERVE CELL; NEUROBLASTOMA CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

MURINAE; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 0347298789     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282403763635474     Document Type: Article

References (47)

1. Arnheiter, H., and O. Haller. 1983. Mx gene control of interferon action: different kinetics of the antiviral state against influenza virus and vesicular stomatitis virus. J. Virol. 47:626-630.
2. Balachandran, S., P.C. Roberts, L.E. Brown, et al. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-41.
3. Beattie, E., K.L. Denzler, J. Tartaglia, et al. 1995. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:499-505.
4. Beretta, L., M. Gabbay, R. Berger, et al. 1996. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q-associated leukemias. Oncogene 12:1593-1596.
5. Bergmann, M., A. Garcia-Sastre, E. Carnero, et al. 2000. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74:6203-6206.
6. Bi, Z., M. Barna, T. Komatsu, et al. 1995. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 69:6466-6472.
7. Bi, Z., and C.S. Reiss. 1995. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:2208-2213.
8. Carpick, B.W., V. Graziano, D. Schneider, et al. 1997. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-1 transactivating region RNA. J. Biol. Chem. 272:9510-9516.
9. Castelli, J.C., B.A. Hassel, K.A. Wood, et al. 1997. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J. Exp. Med. 186:967-972.
10. Chesler, D.A., C. Dodard, J.A. McCutcheon, G.Y Lee, D.E. Levy, C.S. Reiss. 2003. The IFN-γ-induced antiviral response to neuronal VSV infection is STAT1-dependent and neuronal nitric oxide synthetase expression post-transcriptionally regulated. J. Immunol. (submitted).
11. Christian, A.Y., M. Bama, Z. Bi, et al. 1996. Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice. Viral Immunol 9:195-205.
12. Clemens, M.J. 1997. PKR - a protein kinase regulated by double-stranded RNA. Int J Biochem Cell Biol 29:945-949.
13. Clemens, M.J., and A. Elia. 1997. The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 17:503-524.
14. Durbin, R.K., S.E. Mertz, A.E. Koromilas, et al. 2002. PKR protection against intranasal vesicular stomatitis virus infection is mouse strain-dependent. Viral Immunol 15:41-51.
15. Farrar, M.A., and R.D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11:571-611.
16. Gale, M.J., Jr., M.J. Korth, and M.G. Katze. 1998. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clin Diagn Virol 10:157-162.
17. Garcia-Sastre, A., A. Egorov, D. Matassov, et al. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324-330.
18. Guidotti, L.G., and F.V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19:65-91.
19. Hatada, E., S. Saito, and R. Fukuda. 1999. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol 73:2425-2433.
20. Horisberger, M.A., P. Staeheli, and O. Haller. 1983. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad Sci USA 80:1910-1914.
21. Hu, Y., and T.W. Conway. 1993. 2-Aminopurine inhibits the double-stranded RNA-dependent protein kinase both in vitro and in vivo. J Interferon Res 13:323-328.
22. Huneycutt, B.S., Z. Bi, C.J. Aoki, et al. 1993. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J Virol 67:6698-6708.
23. 2-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol. Cell. Biol. 20:617-627.
24. Ireland, D.D., T. Bang, T. Komatsu, et al. 1999. Delayed administration of interleukin-12 is efficacious in promoting recovery from lethal viral encephalitis. Viral. Immunol. 12:35-40.
25. Ischiropoulos, H., and A.B. al-Mehdi. 1995. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 364:279-282.
26. Jacobs, B.L., and J.O. Langland. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339-349.
27. Jeffrey, I.W., S. Kadereit, E.F. Meurs, et al. 1995. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp. Cell. Res. 218:17-27.
28. Khabar, K.S., M. Dhalla, Y. Siddiqui, et al. 2000. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res. 20:653-659.
29. Komatsu, T., M. Barna, and C.S. Reiss. 1997. Interleukin-12 promotes recovery from viral encephalitis. Viral Immunol. 10:35-47.
30. Komatsu, T., Z. Bi, and C.S. Reiss. 1996. Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68:101-108.
31. Komatsu, T., D.D. Ireland, N. Chen, et al. 1999. Neuronal expression of NOS-1 is required for host recovery from viral encephalitis. Virology 258:389-395.
32. Komatsu, T., D.D. Ireland, N. Chen, et al. 1999. Neuronal expression of NOS-1 is required for host recovery from viral encephalitis. Virology 258:389-395.
33. Komatsu, T., N. Srivastava, M. Revzin, et al. 1999. Mechanisms of cytokine-mediated inhibition of viral replication. Virology 259:334-341.
34. Lee, S.B., R. Bablanian, and M. Esteban. 1996. Regulated expression of the interferon-induced protein kinase p68 (PKR) by vaccinia virus recombinants inhibits the replication of vesicular stomatitis virus but not that of poliovirus. J. Interferon Cytokine Res. 16:1073-1078.
35. Norton, G.P., T. Tanaka, K. Tobita, et al. 1987. Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology 156:204-213.
36. Plakhov, I.V., E.E. Arlund, C. Aoki, et al. 1995. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 209:257-262.
37. Rebouillat, D., and A.G. Hovanessian. 1999. The human 2′,5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J. Interferon Cytokine Res. 19:295-308.
38. Reiss, C.S., D.A. Chesler, J. Hodges, et al. 2002. Protective and pathological immune responses in the CNS. Curr. Top. Microbiol. Immunol. 265:63-94.
39. Reiss, C.S., T. Komatsu, M. Barna, et al. 1996. Interleukin-12 promotes enhanced recovery from viral infection of neurons in the central nervous system. Ann NY Acad Sci 795:257-265.
40. Rose, J.K., and M.A. Whitt. 2001. Rhabdoviridae: the viruses and their replication, pp. 665-688. In: D. Knipe and P.M. Howley (eds.). Fundamental Virology. Lippincott Williams & Wilkins, Philadelphia.
41. Sabin, A.B., and P.K. Olitsky. 1937. Influence of host factors on the neuroinvasiveness of vesicular stomatitis virus. Effect of age on the invasion of the brain by virus instilled in the nose. J. Exp. Med. 66:15.
42. Samuel, C.E. 1994. Interferon-induced proteins and their mechanisms of action. Hokkaido Igaku Zasshi 69:1339-1347.
43. Sharp, T.V., F. Moonan, A. Romashko, et al. 1998. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation. Virology 250:302-315.
44. Stojdl, D.F., N. Abraham, S. Knowles, et al. 2000. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J. Virol. 74:9580-9585.
45. Tan, S.L., and M.G. Katze. 1998. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J. Interferon Cytokine Res. 18:757-766.
46. Tanaka, H., and C.E. Samuel. 1994. Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 91:7995-7999.
47. Taylor, D.R., S.T. Shi, P.R. Romano, et al. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107-110.